Clinically, monocytes from individuals with severe OSA present with higher NLRP3 activity than those from control subjects, which directly correlates with the apnea–hypopnea index (AHI) and hypoxemic indices [81]. The gene discussed is NLRP3; the disease is obstructive sleep apnea syndrome.